[144] Concentrix Corporation SEC Filing

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

144

07/08/2025 - 04:48 PM

144: Filer Information

Filer CIK

Filer CCC

Is this a LIVE or TEST Filing?

LIVE TEST

Submission Contact Information

Name

Phone

E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold

Name and Address of the Broker

Number of Shares or Other Units To Be Sold

Aggregate Market Value

Number of Shares or Other Units Outstanding

Approximate Date of Sale

Name the Securities Exchange

Common Stock

Goldman Sachs & Co. LLC
200 West Street
New York NY 10282

300000

18150000

63025120

07/08/2025

NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class

Date you Acquired

Nature of Acquisition Transaction

Name of Person from Whom Acquired

Is this a Gift?

Date Donor Acquired

Amount of Securities Acquired

Date of Payment

Nature of Payment *

Common Stock

09/25/2023

Acquired as consideration of merger or acquisition

Issuer

150000

09/25/2023

Securities

Common Stock

09/25/2023

Acquired as consideration of merger or acquisition

Issuer

150000

09/25/2023

Securities

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller

Title of Securities Sold

Date of Sale

Amount of Securities Sold

Gross Proceeds

Liberty Management
39899 Balentine Drive
Suite 235
Newark CA 94560

Common stock

04/15/2025

19366

943118.39

Olivier Fabrice Duha
39899 Balentine Drive
Suite 235
Newark CA 94560

Common stock

04/15/2025

29444

1428684.71

Celeste Investissements
39899 Balentine Drive
Suite 235
Newark CA 94560

Common stock

04/15/2025

29706

1441465.83

Olivier Fabrice Duha
39899 Balentine Drive
Suite 235
Newark CA 94560

Common stock

04/16/2025

11512

554870.34

Liberty Management
39899 Balentine Drive
Suite 235
Newark CA 94560

Common stock

04/16/2025

7176

345934.15

Celeste Investissements
39899 Balentine Drive
Suite 235
Newark CA 94560

Common stock

04/16/2025

11639

560905.52

Olivier Fabrice Duha
39899 Balentine Drive
Suite 235
Newark CA 94560

Common stock

07/02/2025

20251

1145570.72

Liberty Management
39899 Balentine Drive
Suite 235
Newark CA 94560

Common stock

07/02/2025

9499

535930.73

Celeste Investissements
39899 Balentine Drive
Suite 235
Newark CA 94560

Common stock

07/02/2025

20250

1145499.98

Olivier Fabrice Duha
39899 Balentine Drive
Suite 235
Newark CA 94560

Common stock

07/08/2025

70773

4275963.11

Celeste Investissements
39899 Balentine Drive
Suite 235
Newark CA 94560

Common stock

07/08/2025

70384

4250334.92

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Source:

AG真人官方